inclusion criteria: * patient understands the procedures and requirements and is willing and able to give informed consent for full participation in the study. * previously healthy adults, male or female, aged 18 to 60 years at time of consent with early symptomatic covid-19 * sars-cov-2 positive by lateral flow antigen test or a positive pcr test for sars-cov-2 within the last 24hrs with a ct value of less than 25 (all viral targets) * symptoms of covid-19 (including fever, or history of fever) for less than 4 days (96 hours). * oxygen saturation ≥96% measured by pulse-oximetry at time of screening. * able to walk unaided and unimpeded in adls * agrees and is able to adhere to all study procedures, including availability and contact information for follow-up visits

inclusion criteria: * patient understands the procedures and requirements and is willing and able to give informed consent for full participation in the study. * previously healthy adults, male or female, aged 18 to 60 years at time of consent with early symptomatic covid-19 * sars-cov-2 positive by lateral flow antigen test or a positive pcr test for sars-cov-2 within the last 24hrs with a ct value of less than 25 (all viral targets) * symptoms of covid-19 (including fever, or history of fever) for less than 4 days (96 hours). * oxygen saturation ≥96% measured by pulse-oximetry at time of screening. * able to walk unaided and unimpeded in adls * agrees and is able to adhere to all study procedures, including availability and contact information for follow-up visits

inclusion criteria: patient understands the procedures and requirements and is willing and able to give informed consent for full participation in the study. previously healthy adults, male or female, aged 18 to 60 years at time of consent with early symptomatic covid-19 sars-cov-2 positive by lateral flow antigen test or a positive pcr test for sars-cov-2 within the last 24hrs with a ct value of less than 25 (all viral targets) symptoms of covid-19 (including fever, or history of fever) for less than 4 days (96 hours). oxygen saturation ≥96% measured by pulse-oximetry at time of screening. able to walk unaided and unimpeded in adls agrees and is able to adhere to all study procedures, including availability and contact information for follow-up visits

inclusion criteria: patient understands the procedures and requirements and is willing and able to give informed consent for full participation in the study. previously healthy adults, male or female, aged 18 to 60 years at time of consent with early symptomatic covid-19 sars-cov-2 positive by lateral flow antigen test or a positive pcr test for sars-cov-2 within the last 24hrs with a ct value of less than 25 (all viral targets) symptoms of covid-19 (including fever, or history of fever) for less than 4 days (96 hours). oxygen saturation ≥96% measured by pulse-oximetry at time of screening. able to walk unaided and unimpeded in adls agrees and is able to adhere to all study procedures, including availability and contact information for follow-up visits

inclusion criteria: patient understands the procedures and requirements and is willing and able to give informed consent for full participation in the study. previously healthy adults, male or female, aged 18 to 50 years at time of consent with early symptomatic covid-19 sars-cov-2 positive by lateral flow antigen test or a positive pcr test for sars-cov-2 within the last 24hrs with a ct value of less than 25 (all viral targets) symptoms of covid-19 (including fever, or history of fever) for less than 4 days (96 hours). oxygen saturation ≥96% measured by pulse-oximetry at time of screening. able to walk unaided and unimpeded in adls agrees and is able to adhere to all study procedures, including availability and contact information for follow-up visits

inclusion criteria: patient understands the procedures and requirements and is willing and able to give informed consent for full participation in the study. previously healthy adults, male or female, aged 18 to 50 years at time of consent with early symptomatic covid-19 sars-cov-2 positive by lateral flow antigen test or a positive pcr test for sars-cov-2 within the last 24hrs with a ct value of less than 25 (all viral targets) symptoms of covid-19 (including fever, or history of fever) for less than 4 days (96 hours). oxygen saturation ≥96% measured by pulse-oximetry at time of screening. able to walk unaided and unimpeded in adls agrees and is able to adhere to all study procedures, including availability and contact information for follow-up visits

inclusion criteria: - patient understands the procedures and requirements and is willing and able to give informed consent for full participation in the study. - previously healthy adults, male or female, aged 18 to 50 years at time of consent with early symptomatic covid-19 - sars-cov-2 positive by lateral flow antigen test - symptoms of covid-19 (including fever, or history of fever) for less than 4 days (96 hours). - oxygen saturation ≥96% measured by pulse-oximetry at time of screening. - able to walk unaided and unimpeded in adls - agrees and is able to adhere to all study procedures, including availability and contact information for follow-up visits

inclusion criteria: - patient understands the procedures and requirements and is willing and able to give informed consent for full participation in the study. - previously healthy adults, male or female, aged 18 to 50 years at time of consent with early symptomatic covid-19 - sars-cov-2 positive by lateral flow antigen test - symptoms of covid-19 (including fever, or history of fever) for less than 4 days (96 hours). - oxygen saturation ≥96% measured by pulse-oximetry at time of screening. - able to walk unaided and unimpeded in adls - agrees and is able to adhere to all study procedures, including availability and contact information for follow-up visits